The 10-second takeaway
For the quarter ended June 30 (Q2), athenahealth met expectations on revenues and beat expectations on earnings per share.
Compared to the prior-year quarter, revenue grew significantly and GAAP earnings per share dropped significantly.
Margins dropped across the board.
athenahealth tallied revenue of $103.5 million. The 19 analysts polled by S&P Capital IQ looked for revenue of $103.8 million on the same basis. GAAP reported sales were 33% higher than the prior-year quarter's $77.9 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
EPS came in at $0.24. The 16 earnings estimates compiled by S&P Capital IQ predicted $0.23 per share. GAAP EPS of $0.11 for Q2 were 21% lower than the prior-year quarter's $0.14 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the quarter, gross margin was 60.4%, 230 basis points worse than the prior-year quarter. Operating margin was 6.5%, 560 basis points worse than the prior-year quarter. Net margin was 4.0%, 270 basis points worse than the prior-year quarter.
The stock has a two-star rating (out of five) at Motley Fool CAPS, with 188 members out of 239 rating the stock outperform, and 51 members rating it underperform. Among 62 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 47 give athenahealth a green thumbs-up, and 15 give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on athenahealth is hold, with an average price target of $65.00.
- Add athenahealth to My Watchlist.